Bayer Ups Yaz Lawsuit Settlements as Drugs Rank Second In Side Effects

The Yaz Resource Center is the Web’s largest source for information on Yaz research, side effects and legal news. Visit http://www.YazLawsuit.com

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
yaz lawsuit
Anyone who took Yaz or Yasmin and suffered a blood clot, DVT, stroke or Pulmonary Embolism is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.

Dallas, TX (PRWEB) August 21, 2012

The Yaz Resource Center, a patient advocacy group, is alerting women who have suffered side effects after taking the birth control drugs Yaz or Yasmin that the medications were recently ranked among the highest for side effects. Also, the maker of the drugs, Bayer, has pledged more funds to resolve claims by those injured. However, the time to file a claim is limited.

Anyone who took Yaz or Yasmin and suffered a blood clot, DVT, stroke or Pulmonary Embolism is urged to contact the Yaz Resource Center or speak with a lawyer about their legal options.

On October 25, 2011, the British Medical Journal published a study from researchers at The University of Copenhagen which related the hormone in Yaz to blood clots.

The FDA followed on October 27, 2011, releasing its own study of more than 800,000 women titled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" which found drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.

On May 31, 2012, the Institute for Safe Medicine Practices published its QuarterWatch report which ranked Yaz and Yasmin as the second-worst drugs in 2011 for the number of complications reported to the FDA.

Due to the number of Yaz lawsuits that patients have filed, a federal panel established a Multi-District Litigation court in Illinois to handle the claims. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100). The court estimates more than 11,000 patients have filed a claim so far.

Bloomberg News reported on July 31st that Bayer has settled nearly 1900 Yaz lawsuits so far for more than $400 million, at an average of around $212,000. The article also indicates Bayer has more than doubled its reserves for settling these cases to over $610 million, which could be positive news for those injured who have yet to file a claim.

Anyone affected by blood clots, stroke, DVT or pulmonary embolism after taking Yaz should learn their legal rights as soon as possible and find out whether Yaz litigation may be an option.

The Yaz Resource Center cautions those who are contacted with offers of a quick Yaz settlement. Victims should make sure they choose a lawyer with experience in defective drug litigation. The Resource Center only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on research, side effects and litigation news related to the drug Yaz, or to speak with a lawyer, visit http://www.YazLawsuit.com.


Contact